(no title)
medstrom | 1 month ago
You realize this sentence is an oxymoron?
Unless you meant to say "it does not cause the development of heart disease". I agree correlation is not causation.
medstrom | 1 month ago
You realize this sentence is an oxymoron?
Unless you meant to say "it does not cause the development of heart disease". I agree correlation is not causation.
rowanG077|1 month ago
smt88|1 month ago
No it isn't.
Think of heart disease as slow, long-term damage to the cardiovascular system, and cholesterol is what the body uses as a bandaid.
If you have a lot of LDL cholesterol available, your body will use a lot of it, and you'll have stiffer arteries. If you don't have much available, it takes longer for the bandaids to build up.
This is one of the reasons statins reduce the number of heart attacks, but don't always seem to reduce all-cause mortality.
KempyKolibri|1 month ago
> This is one of the reasons statins reduce the number of heart attacks, but don't always seem to reduce all-cause mortality.
That’s one potential explanation, but I don’t think it’s the most likely one. We tend to see non significant ACM in smaller, less powered trials, or those with lower LDL-c lowering. ACM is simply a less sensitive endpoint - if you have a treatment that reduces CVD incidence, then the “CVD incidence” endpoint will give you significant results with fewer CVD event differences between study arms compared to ACM since your power to detect differences is diluted by other fatal events that aren’t affected by statins (cancer, motor accidents etc).
elromulous|1 month ago
Edit: this was written before OP edited their comment